Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.34 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 7/20 | 0.32 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | IL6ST | P40189 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12533450 | 0.92 | PPARA (0.36) | PPARACSNK2BCSNK2A1IDH1AADAT | |
| SCHEMBL15132901 | 0.81 | PPARA (0.37) | PPARACSNK2BCSNK2A1IDH1CYP3A4 | |
| SCHEMBL15132883 | 0.81 | CYP3A4 (0.37) | PPARACSNK2BCSNK2A1IDH1CYP3A4 | |
| SCHEMBL10157233 | 0.81 | CYP3A4 (0.37) | PPARACSNK2BCSNK2A1IDH1CYP3A4 | |
| SCHEMBL6121101 | 0.79 | — | — | |
| SCHEMBL8511405 | 0.79 | — | — | |
| SCHEMBL21526950 | 0.76 | CYP3A4 (0.40) | PPARACSNK2BCSNK2A1IDH1CYP3A4 | |
| SCHEMBL10157253 | 0.75 | PPARA (0.36) | PPARACSNK2BCSNK2A1IDH1CYP3A4 | |
| SCHEMBL14971787 | 0.75 | CYP3A4 (0.39) | PPARAIDH1CYP3A4 | |
| SCHEMBL15993120 | 0.75 | CYP3A4 (0.39) | PPARAIDH1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2220095-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | GILEAD SCIENCES INC (US) | 2013-01-02 | — | — | EP | disclosed |